France· FR:63646237
NUWIQ 3000 UI, poudre et solvant pour solution injectable
A simoctocog alfa product containing simoctocog alfa, registered in France by OCTAPHARMA (SUEDE). The same ATC class is registered in 2 of our 19 countries.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
Where it is registered
Simoctocog alfa is registered in 2 of 19 countries.
Countries holding a registration under ATC B02BD44 (simoctocog alfa), each read from that country’s own register.
- This record: France, from Base de données publique des médicaments — BDPM (France)
- 1 of them publish a price we can compare per daily dose
Simoctocog alfa · ATC B02BD44
2 / 19 countries
- Franceprice
- United Kingdom
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- SIMOCTOCOG ALFA
- Manufacturer
- OCTAPHARMA (SUEDE)
- Country
- France (FR)
- ATC code
- B02BD44
- ATC class
- Simoctocog alfa
- Defined daily dose
- 1 TSD, E
- Reimbursed
- No
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
- cip1334009550527391 flacon en verre de 3000 UI - 1 seringue préremplie en verre borosilicaté de 2,5 mL + 1 dispositif de transfert pour flacon + 1 aiguille + 2 tampons alcoolisés
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Simoctocog alfa in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- NetherlandsNuwiq 3000 IE poeder en oplosmiddel voor oplossing voor injectieOctapharma AB
- BelgiumNuwiq 1000 IUOctapharma
- FinlandNuwiqOctapharma AB
- IrelandNuwiq 1000 IU powder and solvent for solution for injectionOctapharma AB
- PolandNuwiqOctapharma AB
- SwedenNuwiq 1000 IE Pulver och vätska till injektionsvätska, lösningOctapharma AB
- SpainNUWIQ 1000 UI POLVO Y DISOLVENTE PARA SOLUCION INYECTABLEOctapharma Ab
- CzechiaNUWIQOctapharma AB, Stockholm
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Nuwiq
- Liechtenstein · Nuwiq
- Norway · Nuwiq
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ac87faaa-aa54-4bb3-b6e9-a829aa44ed82 GET /v1/drugs/ac87faaa-aa54-4bb3-b6e9-a829aa44ed82?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "63646237",
"date_amm": "2018-03-23",
"type_amm": "Procédure centralisée",
"numero_ue": "EU/1/14/936",
"substance": "SIMOCTOCOG ALFA",
"atc_source": "fr_atc_restore_2026-09-06",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "poudre et solvant pour solution injectable",
"voies_administration": "intraveineuse",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about simoctocog alfa.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.